NEW YORK (GenomeWeb News) - Cyntellect said today it has received a Phase II Small Business Innovative Research grant from the National Cancer Institute worth $1.3 million to develop applications for its LEAP cell-imaging system.
LEAP (Laser-Enabled Analysis and Processing) is designed for high-throughput cell imaging and laser-based cell manipulation, the company said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.